MedTrace Logo

First-trimester Placental Ultrasound Study

NCT05326191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2023-12-15

No results posted yet for this study

Summary

An observational cohort study to assess the clinical utility of the OxNNet Toolkit for the prediction of adverse pregnancy outcomes.

Conditions

  • Fetal Growth Complications
  • Pregnancy Complications

Interventions

DIAGNOSTIC_TEST

Ultrasound

All study interventions/procedures will happen during the participants routine clinic visit in which they will receive their routine Ultrasound scan, followed by an additional research scan, which will take approximately 2-3 minutes. A blood sample will also be taken from participants as part of their routine pregnancy care. Residual blood from the same sample will be used to conduct an additional test to quantify Placental Growth Factor (PlGF). Participants will also be asked questions about their relevant medical history and demographic data which is also routinely collected as part of their pregnancy record.

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Fetal Medicine Foundation

    collaborator OTHER

  • Perspectum

    lead INDUSTRY

Principal Investigators

  • Kypros Nicolaides, BSc, MMBS · Fetal Medicine Foundation

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2022-11-14
Completion
2023-05-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05326191 on ClinicalTrials.gov